MMM Stock Analysis: 3M | NYSE
Conglomerates | NYSE, USA | Market Cap: 90.540m USD | 12M Return: 3.8% | US88579Y1010 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 544M
EPS Trend: -42.7%
Qual. Beats: 3
Rev. Trend: -75.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
3M Company (NYSE: MMM) is a diversified industrial conglomerate operating through three core segments: Safety and Industrial, Transportation and Electronics, and Consumer. The Safety and Industrial segment provides abrasives, adhesives, electrical products, and personal protective equipment. The Transportation and Electronics segment supplies ceramic solutions, bonding and sound management products for vehicles, graphic films, semiconductor production materials, and data center solutions. The Consumer segment offers household cleaning products, air quality solutions, office and stationery items, and consumer health products such as bandages and braces.
The company serves a broad set of end markets, including automotive, electronics, construction, manufacturing, energy, government, and transportation. As an industrial conglomerate, 3Ms structure spans unrelated business lines within a single corporate parent, a defining feature of the GICS Industrial Conglomerates sub-industry that is designed to balance exposure across cyclical and consumer-driven markets. The company distributes through e-commerce, wholesalers, retailers, distributors, dealers, and direct sales channels, providing multiple paths to market.
3M was founded in 1902 and is headquartered in Saint Paul, Minnesota. It is listed on the NYSE under the ticker MMM, is classified within the GICS Industrials sector, and qualifies as a large-cap equity.
- PFAS litigation costs and settlement negotiations pressure earnings outlook
- Solventum spinoff completion refocuses portfolio on industrial segments
- Consumer segment revenue declines amid weak retail demand
| Net Income: 3.54b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.55 > 1.0 |
| NWC/Revenue: 19.19% < 20% (prev 29.63%; Δ -10.44% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.63b > Net Income 3.54b |
| Net Debt (10.4b) to EBITDA (6.12b): 1.70 < 3 |
| Current Ratio: 1.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (522.6m) vs 12m ago -3.60% < -2% |
| Gross Margin: 39.53% > 18% (prev 40.61%; Δ -1.08% > 0.5%) |
| Asset Turnover: 65.46% > 50% (prev 66.00%; Δ -0.54% > 0%) |
| Interest Coverage Ratio: 6.51 > 6 (EBIT TTM 4.69b / Interest Expense TTM 720.0m) |
| A: 0.12 (Total Current Assets 16.7b - Total Current Liabilities 11.9b) / Total Assets 39.5b |
| B: 1.00 (Retained Earnings 39.6b / Total Assets 39.5b) |
| C: 0.12 (EBIT TTM 4.69b / Avg Total Assets 38.6b) |
| D: 0.12 (Book Value of Equity 4.13b / Total Liabilities 34.4b) |
| Altman-Z'' = 5.01 = AAA |
| DSRI: 1.07 (Receivables 4.12b/3.78b, Revenue 25.2b/24.8b) |
| GMI: 1.03 (GM 40.61% / 39.53%) |
| AQI: 1.10 (AQ_t 0.40 / AQ_t-1 0.37) |
| SGI: 1.02 (Revenue 25.2b / 24.8b) |
| TATA: -0.00 (NI 3.54b - CFO 3.63b) / TA 39.5b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of October 28, 2026, the stock is trading at USD 171.58 with a total of 2,707,477 shares traded. Over the past week, the price has changed by +0.12%, over one month by +1.24%, over three months by -3.31% and over the past year by +3.77%.
Current recommended Stop Loss: 166.60 (which is 2.9% or 1.2 ATR below the current price).
3M has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold MMM.
- StrongBuy: 8
- Buy: 1
- Hold: 8
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 190 | 10.7% |
P/E Trailing = 26.0862
P/E Forward = 17.8253
P/S = 3.5862
P/B = 29.7519
P/EG = 1.6065
Revenue TTM = 25.2b USD
EBIT TTM = 4.69b USD
EBITDA TTM = 6.12b USD
Long Term Debt = 10.9b USD (from longTermDebt, last fiscal year)
Short Term Debt = 2.44b USD (from shortTermDebt, last quarter)
Debt = 15.6b USD (from shortLongTermDebtTotal, last quarter) + Leases 553.0m
Net Debt = 10.4b USD (calculated: Debt 15.6b - CCE 5.14b)
Enterprise Value = 101b USD (90.5b + Debt 15.6b - CCE 5.14b)
Interest Coverage Ratio = 6.51 (Ebit TTM 4.69b / Interest Expense TTM 720.0m)
EV/FCF = 37.71x (Enterprise Value 101b / FCF TTM 2.68b)
FCF Yield = 2.65% (FCF TTM 2.68b / Enterprise Value 101b)
FCF Margin = 10.60% (FCF TTM 2.68b / Revenue TTM 25.2b)
Net Margin = 14.01% (Net Income TTM 3.54b / Revenue TTM 25.2b)
Gross Margin = 39.53% ((Revenue TTM 25.2b - Cost of Revenue TTM 15.3b) / Revenue TTM)
Gross Margin QoQ = 42.27% (prev 41.28%)
Tobins Q-Ratio = 2.55 (Enterprise Value 101b / Total Assets 39.5b)
Interest Expense / Debt = 4.63% (Interest Expense 720.0m / Debt 15.6b)
Taxrate = 19.20% (850.0m / 4.43b)
NOPAT = 3.79b (EBIT 4.69b * (1 - 19.20%))
Current Ratio = 1.41 (Total Current Assets 16.7b / Total Current Liabilities 11.9b)
Debt / Equity = 3.77 (Debt 15.6b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 1.70 (Net Debt 10.4b / EBITDA 6.12b)
Debt / FCF = 3.89 (Net Debt 10.4b / FCF TTM 2.68b)
Total Stockholder Equity = 3.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.17% (Net Income 3.54b / Total Assets 39.5b)
RoE = 94.02% (Net Income TTM 3.54b / Total Stockholder Equity 3.76b)
RoCE = 31.91% (EBIT 4.69b / Capital Employed (Equity 3.76b + L.T.Debt 10.9b))
RoIC = 13.14% (NOPAT 3.79b / Invested Capital 28.8b)
WACC = 7.40% (E(90.5b)/V(106b) * Re(8.03%) + D(15.6b)/V(106b) * Rd(4.63%) * (1-Tc(0.19)))
Discount Rate = 8.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.64 | Cagr: -2.62%
[DCF] Terminal Value 77.97% ; FCFF base≈2.24b ; Y1≈2.57b ; Y5≈3.78b
[DCF] Fair Price = 90.16 (EV 56.9b - Net Debt 10.4b = Equity 46.5b / Shares 515.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -42.66 | EPS CAGR: -3.84% | SUE: 2.36 | # QB: 3
Revenue Correlation: -75.57 | Revenue CAGR: -7.83% | SUE: -0.10 | # QB: 0
EPS current Quarter (2027-03-31): EPS=2.29 | Chg30d=+2.16% | Revisions=+25% | Analysts=8
EPS current Year (2026-12-31): EPS=9.13 | Chg30d=+2.02% | Revisions=+10% | GrowthEPS=+13.2% | GrowthRev=+4.8%
EPS next Year (2027-12-31): EPS=9.91 | Chg30d=+1.23% | Revisions=+10% | GrowthEPS=+8.6% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +17% (up=9, down=6)